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Effect of membrane composition and structure on solute re- and a high degree of complement activation were the
moval and biocompatibility in hemodialysis. Significant changes norm. The efficiency of small solute removal by unsubsti-
in extracorporeal membranes have occurred over the past five tuted cellulosic dialyzers improved markedly in the latedecades in which hemodialysis (HD) has been available as a
1960s with the introduction of modified flat-plate dialyz-therapy for both acute renal failure (ARF) and end-stage renal
ers [4], which significantly decreased blood compartmentdisease (ESRD). For cellulosic membranes, these changes have
included a reduction in thickness, hydroxyl group substitution, mass transfer resistance. Solute mass transfer was further
and an increase in pore size. These modifications have resulted improved in the early 1970s when cellulosic hollow fiber
in enhanced efficiency of small solute removal, a broader spec-
membranes [5] began to be offered. Also occurring intrum of overall solute removal, and an attenuation of comple-
this decade was the development of synthetic mem-ment activation in comparison to the thick, unsubstituted cellu-
losic membranes of low permeability used in the early days branes, such as polyacrylonitrile (PAN) and polysulfone
of HD therapy. Synthetic membranes, originally developed [6]. These latter membranes differed fundamentally from
specifically for use in high-flux HD and hemofiltration, have regenerated cellulose not only in their polymeric compo-
also evolved during this same time period. In fact, the initially
sition but also in a number of other features, includingclear distinction between low-flux regenerated cellulosic and
pore size, thickness, and hydrophobicity.high-flux synthetic membranes has become blurred, as mem-
brane formulators have developed products designed to appeal Since these early days of dialysis therapy, additional
to enthusiasts for both membrane formats. The purpose of this membranes have been introduced into both the cellulosic
review is to characterize both the solute removal and biocom- and synthetic classes. An initially clear distinction be-
patibility characteristics of dialysis membranes according to
tween low-flux regenerated cellulosic and high-flux syn-their composition (that is, polymeric makeup) and structure.
thetic membranes has, however, become blurred asIn this regard, the manner in which membrane biocompatibility
interacts with flux is highlighted. membrane formulators have developed products de-
signed to appeal to enthusiasts for both membrane for-
mats. The purpose of this article is to provide an overview
Over the past five decades, hemodialyzers used for of current dialysis membrane technology, emphasizing
acute and chronic renal replacement therapy have contin- the manner in which membrane composition and struc-
uously evolved. Utilization of regenerated cellulose (that ture influence both solute removal capabilities and bio-
is, unsubstituted cellulosic) membranes of small appar- compatibility properties.
ent pore size and large thickness in dialyzers with ineffi-
cient mass transfers characteristics characterized the very
PERMEABILITY CLASSIFICATION OFearly days of hemodialysis (HD) [1–3]. In fact, coil de-
DIALYSIS MEMBRANESsigns with regenerated cellulose tubes were used almost
exclusively throughout the 1960s. Therefore, inefficient Although numerous classification schemes have been
small solute removal, negligible middle molecule removal, proposed [7], HD membranes are traditionally classified
according to water flux, a term synonymous with water
permeability. The clinical parameter used to characterize
Key words: acute renal failure, end-stage renal disease, cellulosic dial-
the water permeability of a dialyzer is the ultrafiltrationysis membranes, synthetic dialysis membranes, hemofiltration, biocom-
patibility, water flux. coefficient (KUF: ml/hr/mm Hg). The water permeability
of a dialyzer is usually derived from in vitro experiments
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low TMP values for all membranes, whereas a plateau The potential dissociation between water and solute
in ultrafiltration rate occurs at relatively high TMP values flux is demonstrated specifically by a Gambro copolymer
[8]. Dialyzer KUF is defined by the slope of the linear membrane containing both hydrophobic (polycarbo-
portion of this ultrafiltration rate versus TMP curve. The nate) and hydrophilic (polyether) domains [9]. Although
membrane characteristic having the largest impact on strictly defined as a synthetic, this membrane’s unique
water permeability is pore size. As discussed by Lysaght composition also endows it with some properties that
[6], ultrafiltrate flux (ultrafiltration rate per unit area of are more characteristic of the cellulosic class. The in vitro
membrane) is roughly proportional to the fourth power vitamin B12 clearance for a 1.1 m2 dialyzer of this type
of the mean membrane pore radius. As such, small (KUF 6.1 ml/hr/mm Hg) is 87 ml/min [10], and the clinical
changes in pore size have a very large effect on water use of this dialyzer achieves a significant (approximately
permeability. 20 to 30%) reduction in serum b2-microglobulin (b2m)
A common misconception relating to dialyzer perfor- concentration [11, 12]. In contrast, unsubstituted cellu-
mance is the assumption that a membrane’s solute re- losic, cellulose acetate, and polysulfone dialyzers with
moval capabilities are necessarily correlated with its water roughly the same KUF and surface area have in vitro
permeability. Diffusion, the predominant mass transfer vitamin B12 clearances of approximately 50 ml/min and
mechanism in HD, can be characterized by solute flux (φ: are unable to achieve a significant reduction in serum
mass removal rate per unit surface area of membrane). b2m concentration in the clinical setting [11]. Ward et al
Based on a model in which a membrane has N (straight) have recently suggested that the mechanism by which
cylindrical pores (per unit membrane surface area) of this membrane can remove b2m despite a low water
radius r, diffusive solute flux can be expressed as [6] permeability is either by adsorption to the hydrophobic
follows: microdomains or by diffusion through the relatively few
large pores in the hydrophilic domains [12]. Unmodifiedφ 5 lDrDC/t (Eq. 1)
cellulosic and cellulose acetate membranes having this
where l is the solute partition coefficient; D is solute same dissociation between water and solute permeability
diffusivity; r is membrane porosity; DC is the transmem- have also been developed recently (discussed later in
brane concentration gradient, and t is membrane thick- this article).
ness. (While the partition coefficient is essentially unity The only dialyzer classification scheme recognized by
for solutes such as urea and creatinine, larger solutes the United States Food and Drug Administration is
with incomplete access to the membrane pores have l based on water permeability, with low and high perme-
values that are less than one.) Membrane porosity is a ability dialyzers having KUF values of ,8 and $8 ml/hr/function of both pore size and number:
mm Hg, respectively. This scheme is at odds with that
r 5 Npr2 (Eq. 2) used primarily in clinical practice in which dialyzers are
divided into low-flux, high-efficiency, and high-flux cate-Equations 1 and 2 suggest that diffusive transport is
gories. This categorization is based primarily on soluterelatively favorable for low molecular weight solutes not
permeability properties. The National Institutes of Healthonly because of the inverse relationship between molecu-
Hemodialysis (HEMO) Study [13] defines low-flux andlar weight and diffusivity, but also because of the greater
high-flux dialyzers as those having a b2m clearance ofaccess of small solutes to the membrane pore structure.
less than 10 ml/min and greater than 20 ml/min duringEquation 1 also indicates that diffusive transport is en-
first use, respectively. (An additional high-flux require-hanced at low values of membrane thickness.
ment is a KUF .14 ml/hr/mm Hg.) The term “high effi-The dissociation between solute and water permeabil-
ciency” actually had its origin as a therapy, first describedity for dialysis membranes can be explained by use of
by Keshaviah et al [14], rather than a specific type ofthe previously mentioned fundamental principles. For
dialyzer. These investigators employed large surface areaall dialysis membranes, small solutes such as urea and
cellulose acetate dialyzers and relatively high blood flowcreatinine have free pore access (l 5 1). Therefore,
rates to achieve sufficiently high urea clearances to allowsmall solute transport is highly dependent on membrane
reductions in treatment time. The use of large surfaceporosity. As equation 2 indicates, one membrane with
area dialyzers capable of achieving these high urea clear-a large number of relatively small pores and a second
ances has increased to the point that a separate, albeitmembrane with a small number of relatively large pores
somewhat indistinct, class of high-efficiency dialyzerscan have equivalent porosities. Although the small solute
now exists. Although this class is defined primarily bytransport properties of these two hypothetical mem-
its solute removal capabilities, dialyzers in this categorybranes would be equivalent, the flux (water permeabil-
generally have KUF values falling in the 8 to 15 ml/hr/ity) properties would greatly differ. This difference is
mm Hg range, essentially bridging the gap between low-explained by the strong dependence of ultrafiltrate flux
on membrane pore size (described earlier in this article). flux and high-flux dialyzers.
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BASIC CHARACTERISTICS OF membranes because of their ability to adsorb these fac-
CELLULOSIC MEMBRANES tors nonspecifically, it appears to play a role for Hemo-
phant also [24]. Finally, a vitamin E-modified cellulosicThe monomeric subunit of cellulosic membranes is
membrane has also been introduced recently [25].cellobiose, a naturally occurring saccharide found in
The SMC membrane, the polycarbonate/polyetherplants [4]. Chemically, cellobiose is a ringed structure
membrane, and certain synthetic membranes, are exam-richly endowed with hydroxyl groups. The interaction
ples of surfaces endowed with microdomain structures.of complement cascade products with these hydroxyl
As discussed recently [21, 26], a membrane having agroups is felt to be responsible, at least partly, for the
combination of hydrophilic and hydrophobic domainsrelatively pronounced complement activation and leuko-
rather than a uniformly hydrophilic or hydrophobic com-penia observed when unsubstituted cellulosic mem-
position has theoretical advantages with respect to bio-branes contact blood [15]. For the past several years,
compatibility. Although hydrophilic surfaces promotea major objective among manufacturers has been the
complement activation, hydrophobic surfaces tend to bedevelopment of modified (substituted) cellulosic mem-
thombogenic because of their ability to adsorb proteinsbranes in which a certain fraction of these hydroxyl
and activate platelets [27]. The purposeful interspersinggroups is replaced with other moieties. The substitution
of hydrophilic and hydrophobic domains in a “checker-groups diminish the degree of complement activation by
board” pattern is designed to strike a balance betweenat least three different mechanisms. One mechanism is
complement activation and thrombogenicity and to en-the replacement of a large percentage of the hydroxyl
hance the overall biocompatibility of the previously men-groups with an acetate radical [5]. (Although the hollow
tioned membranes.fiber membrane produced by Dow in the 1970s was ex-
The evolution in cellulosic membranes has resulted intruded as cellulose acetate, it functionally was regener-
a wide spectrum of biocompatibility and flux profiles. Ifated cellulose due to a de-esterification step in the manu-
complement activation and neutropenia are used as thefacturing process.) In the first truly substituted cellulosic
major biocompatibility criteria [28, 29], regenerated cel-membrane, cellulose (di)acetate, approximately 70 to
lulose is the least biocompatible, whereas cellulose triac-80% of the hydroxyl groups on the cellulosic backbone
etate is the most biocompatible, with the other modifiedwere replaced with an acetate group. Most likely because
cellulosic membranes having intermediate profiles. How-this modification eliminates a large fraction of the active
ever, characterization of the flux properties of these mem-surface sites for interaction with complement compo-
branes is not as straightforward. For dialyzers of compa-nents, an attenuation of the intense complement activa-
rable surface area, a simplistic approach is to reporttion seen with unmodified cellulosics was achieved. This
KUF values in the following ascending order: regeneratedmembrane modification also resulted in a moderate in-
cellulose , Hemophant, SMC , cellulose acetate ,crease in pore size, yielding a slightly higher water per-
cellulose triacetate [10, 30]. In this simplistic scheme, ameability and broader solute removal spectrum for cellu-
1.5 m2 dialyzer having a regenerated cellulose, Hemo-lose acetate in comparison to unsubstituted cellulosic
phant or SMC membrane generally falls in the low-fluxmembranes of similar surface area [14]. Extrapolation of
category (KUF ,8 ml/hr/mm Hg), whereas comparablythis process to total replacement of the hydroxyl groups
sized dialyzers having cellulose acetate and cellulose tri-resulted in the cellulose triacetate fiber characterized by
acetate membranes fall in the mid-flux (KUF 10 to 20further attenuation of complement activation and higher
ml/hr/mm Hg) and high-flux (KUF .20 ml/hr/mm Hg)water permeability [16]. Recent data demonstrate the
categories, respectively. However, this simplistic catego-biocompatibility profiles for high-flux cellulose triacetate
rization scheme breaks down in several respects. High-and polysulfone dialyzers are comparable [16–18].
flux cellulose acetate membranes have now been pro-A second cellulosic substitution mechanism is the re-
duced by two different HD membrane manufacturersplacement of a relatively small percentage (less than 5%)
[18, 31, 32], and cellulose triacetate dialyzers of low waterof the hydroxyl groups with a bulky chemical group,
permeability (KUF 9.5 ml/hr/mm Hg) are also availablewhich sterically reduces the degree of interaction be-
[33]. Finally, the recent development of unmodified cel-tween complement activation products and the mem-
lulosic and cellulose acetate membranes having relativelybrane. Examples for which this strategy is employed are
low water permeability but solute removal capabilitiesHemophant (tertiary amine substitution) [19, 20] and
that include b2m [34, 35] further confounds this classifi-synthetically modified cellulose (SMC; benzyl substitu-
cation scheme and provides additional examples of ation group) [21]. A final mechanism by which complement
dissociation between water and solute flux. Thus, as isactivation can be attenuated is modulation of factors D
the case with synthetic membranes, neither the water norand H, which act as an up-regulator and a down-regula-
solute permeability properties of a cellulosic HD mem-tor, respectively, in the complement cascade [22, 23].
Although this mechanism is most relevant for synthetic brane are defined by its specific polymeric composition.
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BASIC CHARACTERISTICS OF polyethersulfone), a hydrophilic additive [polyvinylpyr-
rolidone (PVP)] acts as a polymer alloy. PVP is used toSYNTHETIC MEMBRANES
impart sufficient hydrophilicity to the membrane to allowThe monomeric subunits of the various synthetic mem-
clinical use and, as a wetting agent, modulates surfacebranes individually vary, and all differ significantly from
tension and viscosity within the pore structure duringcellobiose. The absence of surface hydroxyl groups on
membrane formulation. This latter feature explainssynthetic membranes is one factor responsible for the
PVP’s importance in determining the overall pore sizereported differences in complement activation between
distribution of synthetic membranes.synthetic membranes and either unsubstituted cellulosic
Although synthetic membranes are employed for bothmembranes or modified cellulosic membranes of low per-
hemofiltration and high-flux HD, it is in the latter modemeability. Subsequent to the introduction of the AN69t
that these membranes have found their widest applica-membrane in the early 1970s, numerous synthetic mem-
tion. Another synthetic membrane formulation was re-branes have been introduced for clinical use. Similar to
ported in the late 1980s with the introduction of low-AN69t, polysulfone and polyamide were brought to the
flux versions. Low-flux polysulfone [38] and PMMA [12]market for use in both high-flux HD and hemofiltration
have been used clinically for several years now, and[36, 37]. One obvious reason accounting for the use of
recently, a low-flux version of a polyamide/polyethersul-these membranes in a hemofiltration mode is their sig-
fone copolymer has been introduced (abstract; Kaiser etnificantly larger pore size and higher hydraulic perme-
al, Blood Purif 16:236, 1998). Overall, the percentage ofability than regenerated cellulose membranes. The other
the American HD market employing polysulfone mem-reason relates to the structural differences between the
branes has increased from approximately 10% in thesynthetic and unsubstituted cellulosic membrane groups.
late 1980s to approximately 50% currently. However, inCellulosic membranes have relatively thin walls (gener-
recent years in the United States, the rate of growth inally in the 6 to 15 mm range), which have a uniform (sym-
the use of polysulfone has been more rapid for the low-metric) composition across their entire thickness. Although
flux version than the high-flux version.the relative thinness of cellulosic membranes is desirable
with respect to diffusive solute transport (discussed later
in this article), this same characteristic renders many EFFECT OF MEMBRANE COMPOSITION
AND STRUCTURE ON DIALYTICcellulosic membranes unable to withstand the high ultra-
SOLUTE REMOVALfiltration rates required to perform convective therapies.
The synthetic membranes have thicker walls (20 mm or One classification scheme for uremic solutes is as fol-
more) that may be structurally symmetric [for example, lows: small solutes (molecular wt , 200 Da), most of
AN69t, polymethylmethacrylate (PMMA)] or asymmet- which are nitrogenous in nature, middle molecules (mo-
ric (for example, polysulfone, polyamide). In the latter lecular wt 500 to 2000 Da), and low molecular wt oligo-
category, a very thin “skin” (approximately 1 mm) con- peptides and proteins (molecular wt 2000 to 50,000 Da).
tacting the blood compartment lumen acts primarily as
Small solute removalthe membrane’s separative element with regard to solute
removal, whereas the remaining thickness (stroma) im- Small solute removal during HD occurs almost exclu-
parts mechanical strength. In turn, the composition of sively by diffusion. To quantify a particular membrane’s
the stroma layer is quite variable for the various synthetic diffusive capabilities, its mass transfer resistance is fre-
membranes [37]. For the Fresenius polysulfone membrane quently used [4]:
(Fresenius Medical Care, Bad Homburg, Germany), the
RO 5 RB 1 RM 1 RD (Eq. 3)stroma is relatively homogeneous with a sponge-like struc-
ture, whereas the Gambro polyamide membrane (Gam- In equation 3, the overall resistance to diffusive mass
bro Renal Care, Hechingen, Germany) has, adjacent to transfer of a particular solute (RO) has three components:
the skin, a sponge-like stroma layer that has progres- blood compartment resistance (RB), resistance caused
sively larger pores (“macrovoids” with a finger structure) by the membrane itself (RM), and dialysate compartment
in the radially outward direction. Finally, a new synthetic resistance (RD). Minimizing the mass transfer resistance
(polyethersulfone) membrane developed by Membrana in the blood compartment primarily requires the use of
GmbH (formerly Akzo Nobel) (Wuppertal, Germany) relatively high flow rates (that is, shear rates) that de-
has a novel configuration consisting of a sponge-like crease unstirred layers. Dialysate-side mass transfer re-
stroma layer interposed between skin layers on both sistance is likewise decreased by increasing the flow rate,
the inner (blood-side) and outer (dialysate-side) aspects but optimal dialysate perfusion of fiber bundles is also
(abstract; Kayser et al, J Am Soc Nephrol 8:163A, 1997). a consideration. Although increasing the dialysate flow
In the production of synthetic membranes made of pri- rate may itself improve fiber bundle perfusion (discussed
later in this article), another mechanism by which thismarily hydrophobic polymers (polysulfone, polyamide,
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can be achieved is the inclusion of spacer yarns. These ever, because of its extensive binding to plasma proteins,
devices are spacing filaments placed externally to the this compound is not useful in vivo. In fact, the removal
fibers and are designed to facilitate dialysate distribution of uremic solutes having molecular weights that fall in
and to reduce channeling [39]. The resistance related to the classic middle molecule category has been difficult
the membrane itself actually has two components: to quantify because of the lack of an easily measured in
vivo surrogate molecule. Because recent evidence sug-RM 5 XM/DM (Eq. 4) gests that uremic appetite suppression is mediated by
where XM is the effective diffusion path length for a the retention of a solute(s) in this size range [42], an
solute, and DM is the solute-specific membrane diffusiv- understanding of removal mechanisms for middle mole-
ity. This equation indicates that a decrease in membrane cules is important. Based on dialysis practices used in the
resistance can be achieved either by a decrease in mem- 1960s and early 1970s (that is, relatively low flow rates and
brane thickness or an increase in membrane diffusivity. thick, low permeability cellulosic membranes), diffusive
A recent study published by Murthy et al clearly illus- middle molecule removal was so limited that any convec-
trates the concept that a membrane’s small solute re- tive removal contributed relatively substantially to total
moval capabilities are not necessarily tied to its water removal [41]. However, the situation is vastly different
permeability [35]. Six chronic HD patients were treated in contemporary HD, in which higher flow rates and
with a large surface area unsubstituted cellulosic dialyzer dialyzer membranes of significantly greater diffusive per-
(2.2 m2; KUF, 6 ml/hr/mm Hg) and a high-flux polysulfone meability for middle molecules are employed.
dialyzer (1.8 m2; KUF, 52 ml/hr/mm Hg) in a crossover Agarwal and Cronin assessed middle molecule re-
manner. The mean first-use urea clearance was higher, moval by two high-efficiency dialyzers for seven patients
although not significantly, for the cellulosic dialyzer at studied in a crossover manner [43]. They studied genta-
a blood flow rate of both 300 ml/min (246 6 6 vs. 241 6 micin, a reasonable middle molecule surrogate in light
2 ml/min) and 400 ml/min (288 6 8 vs. 280 6 4 ml/min). of its appropriate molecular weight (518 Da), minimal
This equivalence was achieved despite the substantially protein binding, and small volume of distribution. A
greater pore size and higher water flux of the polysulfone variety of gentamicin removal parameters was determined
membrane. Although the greater surface area of the cellu- for an unsubstituted cellulosic dialyzer (1.75 m2; KUF, 6.0losic dialyzer contributed to this equivalence, the same ml/hr/mm Hg; thickness, 9 mm) and polysulfone (1.8
type of cellulosic dialyzer with a comparable surface area m2; KUF, 8.1 ml/hr/mm Hg; thickness, 40 mm). For both(1.7 m2) has an in vitro urea mass transfer coefficient
dialyzers, an essentially linear relationship between
(permeability-area product: KoA) that is substantially
clearance and blood flow rate was observed, suggestinggreater than that of the 1.8 m2 polysulfone dialyzer stud-
diffusion was the predominant removal mechanism. Atied (1030 and 945 ml/min, respectively) [10]. These find-
blood and dialysate flow rates of approximately 275 andings suggest the significantly lower thickness (9 mm) of
500 ml/min, respectively, gentamicin clearance (58.2 6the cellulosic dialyzer relative to that of the polysulfone
8.0 vs. 41.7 6 6.9 ml/min) and gentamicin KoA (127.3 6dialyzer (40 mm) was an important factor in this study.
6.3 vs. 84.6 6 4.7 ml/min) were significantly greater forAdditional recent data emphasizing the importance
the cellulosic dialyzer. Finally, for the cellulosic dialyzer,of membrane thickness in small solute removal were
these investigations produced a significant linear rela-published by Leypoldt et al [40], who determined in vitro
tionship between urea Kt/V and gentamicin Kt/V (r 5urea KoA values for highly permeable cellulose triacetate
0.87, P 5 0.01). Collectively, these data demonstrate(1.9 m2; KUF, 36 ml/hr/mm Hg) and polysulfone (1.8 m2;
middle molecule removal by the more efficient dialyzersKUF, 55 ml/hr/mm Hg). For blood flow rates ranging
used in contemporary HD is primarily achieved by diffu-between 300 and 450 ml/min and a dialysate flow rate
sion. As such, the use of treatment parameters that favorof 500 ml/min, the mean urea KoA value for the cellulose
diffusive solute removal, such as high flow rates andtriacetate dialyzer (1070 ml/min) was approximately 43%
thin membranes, is expected to produce a concomitanthigher than that of the polysulfone dialyzer (750 ml/min).
increase in middle molecule removal.An increase in the dialysate flow rate to 800 ml/min
Thalhammer et al recently measured dialytic removalresulted in a 15% increase in urea KoA for both dialyz-
parameters for another drug, ofloxacin, whose molecularers, preserving the difference between the dialyzers on
weight (361 Da) also falls in the middle molecule rangea percentage basis. For these dialyzers of comparable
[44]. In a total of 13 patients studied in a noncrossoverwater flux, the probable explanation for this difference
manner, ofloxacin clearance and percentage reductionwas, again, the large difference in membrane thickness
were measured for polysulfone (1.3 m2; KUF, 8.5 ml/hr/(15 vs. 40 mm, cellulose triacetate vs. polysulfone).
mm Hg) and cellulose acetate dialyzers (1.5 m2; KUF, 6.0
Middle molecule removal ml/hr/mm Hg). (The measurements were made during
a period in which the drug was administered 100 mg dailyVitamin B12 (molecular weight, 1350 Da) is commonly
used for in vitro characterizations of dialyzers [41]. How- by mouth.) Mean treatment characteristics included a
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blood flow rate of approximately 250 ml/min and dialy- These recent data demonstrate that, based on the op-
erating conditions and dialyzers used in contemporarysate flow rate of 500 ml/min. Arteriovenous clearance
(108.4 6 15.8 vs. 92.4 6 39.4 ml/min; polysulfone vs. HD, middle molecule removal occurs predominantly by
diffusion. However, middle molecule removal can becellulose acetate) and percentage reduction normalized to
membrane surface area (49.6 6 5.8 vs. 45.5 6 4.8%/m2) did significantly enhanced by convective therapies, such as
hemofiltration and hemodiafiltration, in which an abso-not differ significantly. However, arteriovenous clearance
normalized to the membrane surface area was signifi- lute ultrafiltration rate in excess of that required for
plasma volume reduction is employed [49–51]. In gen-cantly higher for the polysulfone dialyzer (5.0 6 0.7 vs.
3.7 6 1.6 l/hr/m2, P , 0.05). eral, the degree to which convection augments total sol-
ute removal is proportional to solute molecular weightWe have recently reported findings for middle mole-
cule removal by high-flux membranes [45]. The molecu- due to the inverse relationship between solute diffusivity
and size [52].lar weight (1448 Da), protein binding, and volume of
distribution of vancomycin, another antibiotic commonly
Low molecular weight protein removalused in the acute renal failure (ARF) and end-stage renal
disease (ESRD) populations, enable this drug also to be a Recent interest in increasing the extracorporeal re-
moval of b2m has provided insight into the general mech-uremic middle molecule surrogate [46, 47]. We measured
vancomycin removal by a cellulose triacetate dialyzer anisms mediating the removal of low molecular weight
proteins. A number of studies published in the past 15(1.9 m2; KUF, 36 ml/hr/mm Hg) in eight patients who
received 1 g of vancomycin intravenously during the last years [11, 52–63] support several general conclusions.
First, b2m removal by low-flux unsubstituted cellulosichour of dialysis. The mean blood and dialysate flow rates
were 423 and 600 ml/min, respectively. A significant lin- membranes is usually negligible, although certain excep-
tions do exist [35]. Second, the primary mechanism byear correlation (r 5 0.88, P , 0.005) was observed be-
tween the percentage removal of vancomycin and a mea- which b2m is removed during high-flux HD varies widely
among membranes. For certain membranes, such as sul-sure of diffusive small solute removal, urea Kt/V. In
addition, diffusion was determined to account minimally fonated PAN (AN69t) and particularly PMMA, removal
is achieved predominantly or solely by adsorption. Atfor a mean of 92% of total vancomycin removal. In a
subsequent in vitro study [48], we assessed the mass the other end of the spectrum is the cellulose triacetate
membrane, for which adsorption is minimal and removaltransfer of vancomycin and another widely studied large
molecule surrogate, inulin (molecular weight, 5200 Da), occurs primarily by diffusion. High-flux polysulfone and
unsulfonated PAN membranes have intermediate ad-for high-flux cellulose triacetate (1.9 m2; KUF, 36 ml/hr/
mm Hg) and polysulfone (1.8 m2; KUF, 52 ml/hr/mm Hg) sorptive characteristics and achieve transmembrane b2m
removal by a combination of diffusion and convection.dialyzers. This study corroborated the above clinical data
for vancomycin and also suggested that diffusion is the Third, at least for the high-flux synthetic membranes,
enhanced convective removal by the use of high ultrafil-predominant mass transfer mechanism, even for solutes
as large as inulin, for both high-flux dialyzers. The mean tration rates (with hemofiltration or hemodiafiltration)
increases b2m removal relative to standard (diffusion-first-use inulin clearance was found to be significantly
higher for cellulose triacetate versus polysulfone (76 vs. based) HD. Although many clinicians consider b2m to
be a surrogate for the low molecular weight protein class43 ml/min, respectively, P , 0.05). The lower diffusive
mass transfer resistance of the thinner cellulose triacetate of uremic solutes, this assumption has not been conclu-
sively proved. Nevertheless, it is reasonable to use themembrane may account for these findings. However,
another possible explanation may relate to the pore size abundant transport data available for b2m to provide
insight into the transport characteristics of other lowdimensions of the polysulfone dialyzer specifically used
in the study. This dialyzer, which is designed for units molecular weight proteins, such as complement activa-
tion products and cytokines.employing bleach-based reprocessing, has a relatively
low first-use b2m clearance, which increases significantly We recently measured the protein transport properties
of high-flux membranes. In an initial set of studies [64],when it is reprocessed with bleach [13]. In our study
[48], inulin clearance for the polysulfone dialyzer also fragments of AN69t membranes were incubated in sa-
line containing 125I-labeled b2m. Adsorption isothermsincreased significantly during bleach reprocessing, such
that no significant difference was observed between the (amount of protein adsorbed vs. concentration in solu-
tion at equilibrium) [65] were generated for both poroustwo dialyzers after 10 in vitro reuses. Thus, a difference
in mean pore size may also explain the first-use differ- (commercially available) AN69t and a nonporous prep-
aration of the same polymer. At equivalent solution con-ence for inulin clearance in our study. Of note, relative
to the polysulfone dialyzers used in this study, recent centrations, the b2m binding affinity of the porous PAN
was approximately eight times greater than that of thedata [15] indicate the first-use b2m clearance of more
recently manufactured dialyzers is higher. nonporous PAN. These data indicate that the adsorptive
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Fig. 2. Generation of C3a during incubation of serum with cuprophan
or PAN membranes. Symbols (h cuprophan; PAN) depict the
mean 6 sem (N 5 5). *The difference between cuprophan and PAN
is statistically significant (P , 0.001). (Reprinted with permission fromFig. 1. Isotherm curves for b2-microglobulin (b2m) adsorption to poly- Cheung et al [67] and the International Society of Nephrology.)acrylonitrile (PAN) and cellulose triacetate (CT). The relationship is
linear for both membranes. The slope of the PAN line is approximately
fivefold greater than that of the CT line. (Reprinted with permission
from Clark et al and the International Society of Nephrology [66].)
INTERACTION BETWEEN BIOCOMPATIBILITY
AND FLUX
Measurement of complement pathway byproducts issurface area resides primarily in the pore structure of a
one technique used to assess the inflammatory responsehigh-flux HD membrane rather than the nominal surface
elicited by exposure of blood to a dialysis membrane.
area. As such, the adsorption of a low molecular weight
However, numerous previous studies have failed to ac-
protein is highly dependent on access of the protein count for the fact that the clinically measured comple-
to a membrane’s internal pore structure. Consequently, ment components (C3a and C5a) are low molecular
adsorption of low-molecular weight proteins, such as C3a weight proteins. Therefore, the concentration of these
and b2m, to low-flux membranes is not expected to be inflammatory mediators represents the net result of the
clinically significant, at least in comparison to that which simultaneous processes of generation and any dialytic
occurs to high-flux membranes. removal that may occur. In this regard, complement acti-
We also compared protein removal mechanisms for vation products are similar to most uremic solutes, for
different high-flux membranes [66]. Based on the slopes which both generation and net removal need to be con-
of the equilibrium isotherm curves, we found that the sidered [68]. The corollary of this observation is that
adsorption affinity of AN69t for b2m was approximately the permeability properties and not just the polymeric
five times that of the cellulose triacetate membrane (Fig. composition of a dialysis membrane must be considered
1). This finding was attributed to the greater hydropho- when evaluating complement activation data.
bicity of the synthetic membrane. However, the b2m dif- The effect of simultaneous generation and removal on
fusive mass transfer resistance of the AN69 membrane net complement activation was investigated in a classic
was found to be approximately 1.7-fold greater than that study published by Cheung et al [67]. Dialysis membrane
of cellulose triacetate, a result that translated into an fragments composed of either (low-flux) regenerated cel-
order of magnitude difference in the b2m membrane lulose (Cuprophant) or (high-flux) PAN (AN69t) were
diffusion coefficients (3.25 3 1027 vs. 0.30 3 1027 cm2/ incubated in plasma containing C3 molecules previously
sec; cellulose triacetate vs. AN69t). Thus, in terms of b2m radiolabeled with 125I. After a 30-minute incubation pe-
(and presumably other low molecular weight protein) riod, the generation of C3a (molecular weight, 9.5 kDa)
removal, our findings corroborate previous experimental resulting from contact of the plasma with the membranes
and clinical data demonstrating the high adsorptive af- was measured. For each membrane, total C3a generation
finity of the sulfonated PAN membrane [19, 67]. How- was determined by summing the amount in the supernate
ever, our data also suggest that this membrane is not (fluid phase) and the amount adsorbed to the membrane.
very well suited for diffusive removal of uremic solutes The results (Fig. 2) indicate that the total C3a generation
in this class, at least in comparison to high-flux cellulosic was actually greatest for the “biocompatible” AN69t.
However, nearly all of the C3a generated was rapidlymembranes.
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Table 1. Inflammatory mediators both low-flux and high-flux polysulfone dialyzers [80].
Peak plasma C3a concentrations were approximatelyMolecular
weight twofold higher with the low-flux than the high-flux mem-
Mediator kD brane. In addition, the area under the C3a versus time
Lipid A 2–4 curve, which is a time-integrated measure of complement
Lipopolysaccharide (LPS) fragments ,8
activation, appeared to be significantly higher for the low-C3a 8.9
Granulocyte inhibitory peptide (GIP) II 9.5 flux dialyzer. A similar difference in the extent of comple-
C5a 11 ment activation between low-flux and high-flux polysul-
Interleukin-1 17
fone dialyzers has also been reported by Dumler et alTumor necrosis factor (monomeric) 17
Factor D 23 (abstract; Dumler et al, Blood Purif 10:91–92, 1992). These
Granulocyte inhibitory peptide (GIP) I 28 findings are most likely explained by the ability of the
Tumor necrosis factor (trimeric) 55
high-flux polysulfone membrane to remove a greater pro-Lipopolysaccharide (LPS) .100
portion of the generated complement component, relativeReprinted [71] with permission.
to the low-flux membrane. The larger mean pore size of
the high-flux membrane allows greater pore access of the
generated C3a and subsequent removal by a transmem-
brane (diffusive or convective) or adsorptive mechanism.adsorbed to this hydrophobic membrane. Total C3a gen-
eration was significantly lower for the regenerated cellu- Similar reasoning can be applied to a recent study by
Hoenich et al [34]. These investigators measured serumlose membrane, but virtually all of the protein remained
in the fluid phase rather than being bound to this hydro- C3a concentrations in a group of patients treated with
two cellulose acetate membranes of differing pore sizephilic surface. In extrapolating these data to clinical HD,
a reasonable assumption is that the fluid phase of these and a low-flux polysulfone membrane in a double cross-
over design. The two cellulose acetate membranes hadexperiments corresponds to the venous (dialyzer efflu-
ent) blood line in the extracorporeal circuit. Therefore, reported mean maximum pore radii of 43 and 45 A8.
Despite the similarity in membrane composition, theonly that portion of the generated C3a remaining in the
fluid phase would reach the bloodstream of the patient peak C3a concentration observed for the larger pore
cellulose acetate membrane was significantly less thanto act as a potential inflammatory mediator. These data
are useful in interpreting clinical studies in which com- that of its smaller pore counterpart and was not signifi-
cantly different from that of low-flux polysulfone. Differ-plement protein concentrations are reported and under-
score the need to understand the permeability and solute ences in mean pore size or possibly in pore size distribution
with resultant differences in C3a removal capabilitiesremoval properties of a membrane when evaluating com-
plement activation data. may explain the differences observed for the two cellu-
lose acetate membranes.It is simplistic to limit the discussion about membrane
biocompatibility to complement activation, as a number Deppisch et al have shown that the generation of an-
other inflammatory marker, the terminal complementof agents have been identified as potential inflammatory
mediators in chronic HD patients. A list of these putative complex (TCC), is higher for low-flux than for high-flux
polysulfone [81]. Because of its large molecular size,mediators appears in Table 1 [69, 70] Some of these com-
pounds, such as lipid A and lipopolysacchride fragments, removal of this mediator is not expected to be significant
even by a high-flux HD membrane. Therefore, a mecha-potentially have their origin in dialysate, a nonsterile
fluid [71–73]. Because of their relatively low molecular nism other than enhanced removal of TCC itself, possibly
one related to complement factor D, most likely accountsweight, these inflammatory mediators may undergo trans-
membrane passage and induce cytokine production in for this finding. Factor D is another example of an in-
flammatory mediator that is differentially removed bythe bloodstream, either directly via an effect on mononu-
clear cells or indirectly via an effect on the alternative low-flux and high-flux HD membranes. This compound is
a 23 kDa serine protease whose excretion under normalcomplement pathway [74–78]. Conversely, the majority
of the mediators that are potentially elicited in the blood, circumstances is similar to that of b2m: glomerular filtra-
tion followed by proximal tubule reabsorption/catabo-such as C3a and interleukin-1, may be simultaneously
eliminated during high-flux therapies by an adsorptive lism [17, 82]. Therefore, in patients with ESRD, serum
concentrations are markedly elevated. This protein actsor transmembrane mechanism, as demonstrated in the
Cheung et al study [67]. Other investigations have con- as an up-regulator of the alternative complement path-
way [83], and activation of the alternative pathway byfirmed that adsorption is also important in the removal
of other inflammatory mediators, such as factor D [19] blood–membrane interaction (with resultant C3a gener-
ation) is enhanced in the presence of the high serumand cytokines [79].
Recent clinical data illustrate these concepts. Muller concentrations of factor D found in uremic patients. Re-
cent data demonstrate that factor D removal is negligibleet al measured serial C3a concentrations during HD with
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